BR9814048A - "misturas de enantiÈmetros de aminociclohexil amidas para produzir de modo simultâneo analgesia com anestesia local ou antiarritmia " - Google Patents

"misturas de enantiÈmetros de aminociclohexil amidas para produzir de modo simultâneo analgesia com anestesia local ou antiarritmia "

Info

Publication number
BR9814048A
BR9814048A BR9814048-5A BR9814048A BR9814048A BR 9814048 A BR9814048 A BR 9814048A BR 9814048 A BR9814048 A BR 9814048A BR 9814048 A BR9814048 A BR 9814048A
Authority
BR
Brazil
Prior art keywords
local anesthesia
enantiometers
antiarrhythmia
aminocyclohexyl
mixtures
Prior art date
Application number
BR9814048-5A
Other languages
English (en)
Inventor
Allen I Bain
Original Assignee
Nortran Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nortran Pharmaceuticals Inc filed Critical Nortran Pharmaceuticals Inc
Publication of BR9814048A publication Critical patent/BR9814048A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"MISTURAS DE ENANTIÈMETROS DE AMINOCICLOHEXIL AMIDAS PARA PRODUZIR DE MODO SIMULTâNEO ANALGESIA COM ANESTESIA LOCAL OU ANTIARRITMIA'' A presente invenção proporciona composições e métodos para oferecer analgesia durante o tratamento das arritmias cardíacas ou a indução de anestesia local. As composições da presente invenção incluem uma pluralidade de enantiómetros aminociclohexil amida vicinais em relações de configurações estéreo-específicas.
BR9814048-5A 1997-09-26 1998-09-25 "misturas de enantiÈmetros de aminociclohexil amidas para produzir de modo simultâneo analgesia com anestesia local ou antiarritmia " BR9814048A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6015497P 1997-09-26 1997-09-26
PCT/CA1998/000905 WO1999016431A1 (en) 1997-09-26 1998-09-25 Mixtures of enantiomers of aminocyclohexylamides to produce simultaneous analgesia with local anaesthesia or antiarrhythmia

Publications (1)

Publication Number Publication Date
BR9814048A true BR9814048A (pt) 2000-10-03

Family

ID=22027715

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9814048-5A BR9814048A (pt) 1997-09-26 1998-09-25 "misturas de enantiÈmetros de aminociclohexil amidas para produzir de modo simultâneo analgesia com anestesia local ou antiarritmia "

Country Status (5)

Country Link
CN (1) CN1278166A (pt)
AU (1) AU9248698A (pt)
BR (1) BR9814048A (pt)
MX (1) MXPA00002969A (pt)
WO (1) WO1999016431A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2217742T3 (es) 1998-04-01 2004-11-01 Cardiome Pharma Corp. Compuestos de amino ciclohexil eter y usos del mismo.
US7507545B2 (en) 1999-03-31 2009-03-24 Cardiome Pharma Corp. Ion channel modulating activity method
US7057053B2 (en) 2000-10-06 2006-06-06 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US7524879B2 (en) 2000-10-06 2009-04-28 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
ES2264776T3 (es) 2003-05-02 2007-01-16 Cardiome Pharma Corp. Compuestos de aminociclohexil eter y sus usos.
US7345086B2 (en) 2003-05-02 2008-03-18 Cardiome Pharma Corp. Uses of ion channel modulating compounds
US7674820B2 (en) 2003-08-07 2010-03-09 Cardiome Pharma Corp. Ion channel modulating activity I
US7345087B2 (en) 2003-10-31 2008-03-18 Cardiome Pharma Corp. Aminocyclohexyl ether compounds and uses thereof
WO2005097087A2 (en) 2004-04-01 2005-10-20 Cardiome Pharma Corp. Merged ion channel modulating compounds and uses thereof
EP1729815A2 (en) 2004-04-01 2006-12-13 Cardiome Pharma Corp. Pegylated ion channel modulating compounds
US8263638B2 (en) 2004-11-08 2012-09-11 Cardiome Pharma Corp. Dosing regimens for ion channel modulating compounds
US10160727B2 (en) 2014-08-06 2018-12-25 Shionogi & Co., Ltd. Heterocycle and carbocycle derivatives having TrkA inhibitory activity
WO2017006953A1 (ja) 2015-07-07 2017-01-12 塩野義製薬株式会社 ＴｒｋＡ阻害活性を有する複素環誘導体
JP6898043B2 (ja) 2016-02-04 2021-07-07 塩野義製薬株式会社 ＴｒｋＡ阻害活性を有する含窒素複素環および炭素環誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4212878A (en) * 1978-01-26 1980-07-15 The Upjohn Company Phenylacetamide derivative analgesics
AT376669B (de) * 1982-11-26 1984-12-27 Laevosan Gmbh & Co Kg Verfahren zur herstellung neuer thienylessigsaeureamid-derivate und pharmazeutisch vertraeglicher saeureadditionssalze davon
US5506257A (en) * 1992-03-26 1996-04-09 University Of British Columbia Aminocyclohexylamides for antiarrhythmic and anaesthetic uses

Also Published As

Publication number Publication date
CN1278166A (zh) 2000-12-27
AU9248698A (en) 1999-04-23
WO1999016431A1 (en) 1999-04-08
MXPA00002969A (es) 2002-06-21

Similar Documents

Publication Publication Date Title
BR9814048A (pt) "misturas de enantiÈmetros de aminociclohexil amidas para produzir de modo simultâneo analgesia com anestesia local ou antiarritmia "
DE3469536D1 (en) Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
CA1268123C (en) DIETARY PRODUCTS CONTAINING METHYLSULFONYLMETHANE AND THEIR USE
IL112029A (en) Raloxifine and related compounds for use as medicaments for the treatment of disorders associated with an excess of tachykinin
DE69534468D1 (de) Wachstums-differenzierungsfaktor-11
IT1261949B (it) Composizione terapeutica a base di interferone umano, impiego di interferone umano in tale composizione e relativo metodo.
GEP20002146B (en) Therapeutic Peptide Derivatives
DE69841907D1 (de) Zusammensetzungen enthaltend Capsaicin oder Capsaicin Analoge und ein Anästhetikum
ATE150643T1 (de) Analgetisches mittel und dessen verwendung
FI930912A (fi) Nya cyklosporiner
BR9403783A (pt) Uso de uma composição cosmética
DE69627153D1 (de) Zusammensetzungen zur erzielung von analgesie und zur hemmung der progression neuropathischer schmerzerkrankungen
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
DE69532406D1 (de) Neuartige therapeutische und diätetische verwendungen des auf phospholipiden der hirnsabstanz basierenden komplexes
IL131086A0 (en) The use of levobupivacaine in paediatric surgery
ATE308616T1 (de) Rantes mutanten und deren therapeutische verwendungen
AU9034291A (en) Derivates of the human parathormone fragment (1-37) in the amide or ethylamide form as active substance
GB2236528B (en) Aroyl-ureas
AU3992897A (en) Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psycho-intellectual disorders
ES2058733T3 (es) Metodo para mejorar la ventilacion durante el sueño y para el tratamiento de anormalidades de la ventilacion relacionadas con el sueño.
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
EP0210099A3 (en) Use of n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamide in the treatment of parkinsons's disease
UA15420A (uk) Прилад для рефлексотерапії
UA19504A (uk) Засіб для лікуваhhя гhійhих запалеhь шкіри та підшкірhої клітковиhи
UA10219A (uk) Спосіб лікування туберкульозу легень

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]